Source: Reuters

Roka Bioscience: BRIEF-Roka Bioscience says it entered into fourth amendment to loan and security agreement - SEC Filing

* Roka Bioscience says ‍on Sept 19, 2017, Roka Bioscience entered into fourth amendment to loan and security agreement - SEC Filing

Read full article »
Roka Bioscience's Competitors | Roka Bioscience's News | Roka Bioscience's Financials
Stay up-to-date with the latest news on Roka Bioscience
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Roka Bioscience